Reticular pseudodrusen and subretinal hyperreflective material are among the OCT findings that may predict macular atrophy in ...

ANXV is under clinical development by Annexin Pharmaceuticals and currently in Phase II for Retinal Vein Occlusion.

Ruvembri is under clinical development by Biophytis and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.

A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile ...

Clarity is not rated by Morgans. The retinal-diseases-focused biotech is awaiting two phase III trial results in CY25. The ...

Here's everything you need to know for the 2024 NCAA DIII football championship that features 40 teams battling it out in a single-elimination bracket. The 40-team championship bracket was ...

King Charles III’s health is on the upswing. Amid the British monarch’s ongoing cancer battle, his treatment is “moving in a positive direction,” a Buckingham Palace source told NBC News ...

Bayer announced positive topline results from the global phase III QUASAR study evaluating the efficacy and safety of aflibercept 8 mg in patients with macular edema following retinal vein occlusion ...

Retinal parameters like vessel density (VD) of different compartments of papillary and peripapillary sectors were measured by SS-OCTA, respectively. Two sample-independent T-test was applied to ...

Helmed at a breakneck pace by Jeff Fowler, “Sonic the Hedgehog 3” is loud, chaotic and often corny, with a visual style that ...

Regeneron's phase III study evaluating Eylea HD against stand-of-care Eylea treatment meets the primary endpoint of ...